DJ Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ advanced 1.58% to $125.80 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.17% to 6,771.55 and Dow Jones Industrial Average falling 0.53% to 47,085.24.
This was the stock's second consecutive day of gains.
Abbott Laboratories closed 10.93% below its 52-week high of $141.23, which the company achieved on March 4th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 0.32% to $186.86, Pfizer Inc. $(PFE)$ fell 1.46% to $24.30, and Merck & Co. Inc. $(MRK)$ rose 1.66% to $83.86.
Trading volume (5.6 M) remained 278,439 below its 50-day average volume of 5.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 4, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 04, 2025 16:33 ET (21:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.